AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments. The company develops rapid-acting and durable therapies for conditions with limited treatment options. Its pipeline includes BPL-003 (mebufotenin...
30 insider purchases on record · latest filing 2025-08-18.
Insiders have also filed 15 sale transactions at ATAI.